Truenorth2016
2 days ago
Stervc, you said "In my opinion, I believe they already know what company is coming in here and are simply being patient with taking the proper steps to properly inform the market. This was their first press release in well over 3 years:"
I nibbled and bought 5 Million shares just off this statement. It was tempting to buy all of that .0007 ask but im practicing some discipline and waiting to see what the next PR says. Even if I have to buy a few ticks higher when the news drop, im ok with that. I am not going big in 2025 and beyond until solid news is confimed and these companies PR what they actually did, not what they "plan" on doing.
However, I do agree, this CEO must have something already lined up and being patient and strategic on when to drop the news. Its hard to lie about Quantum Computing. So far 'NO" other OTC is making this claim. If this CEO just said "Artificial Intelligence" alone, I probably wont be that interested, but its speaks volumes when a CEO boldly tell the experienced OTC Trading Community, you have possible merging candidates bringing Quantum Computing to your company.
I have yet to see any OTC stocks subs have a Quantum Computing run, but I have seen at least (20) Nasdaq stocks go from pennies to dollars overnight. This stock has the perfect share structure to surprise everyone and run to dollars just like those NASDAQ Quantum Computing Stocks. Its quiet in here now but I got a feeling it wont be for long.
Sheepdog
2 days ago
You don't get it because you don't want to get it. Saying "for every dollar won in a marketplace someone else had to lose it" is just wrong. Stating so is saying that the cake (company) being split up into pieces (stock) is of finite size and can never change. It is obviously not in non-scam companies. Only some parts of the market are zero sum games, like derivatives or options. Those are indeed "bets" and there is no net gain. However, those are not transactions involving the purchasing of actual equity in the form of stock.
Both parties in a stock transaction can win.
I used the example of Tesla stock earlier (which you discounted because it was not a scam stock, however laughable that was.). While there may have been some losers, NOBODY can deny there has been a NET WIN by investors.
Upon your request, I provided you with links stating you are wrong. Your response was that it is my links that were wrong. Here's Investopedia: Investing long-term is considered a positive-sum situation because capital flows facilitate production and create jobs that then provide savings and income, fueling investment to continue the cycle. Here's wikipedia: The stock market is an excellent example of a positive-sum game, often erroneously labelled as a zero-sum game. This is a zero-sum fallacy: the perception that one trader in the stock market may only increase the value of their holdings if another trader decreases their holdings.
Quit scamming people with your pumping and dumping.
stervc
1 week ago
Sheepdog, respectfully, with GCAN, I strongly disagree...
Respectfully, I strongly disagree with your assessment. GCAN is not a scam in my opinion. Yes, they have had some failed ventures in the past, but that's what hundreds of penny stocks have had before finally getting things right. All they have to do is get it right just one time. They have been staying current with their SEC audited financials for a reason in my opinion. Now they have confirmed such in my opinion with letting the market know that they are exploring merger candidates.
In my opinion, I believe they already know what company is coming in here and are simply being patient with taking the proper steps to properly inform the market. This was their first press release in well over 3 years:
GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=3089966
I have a feeling that they have much more coming to say to the market that will result in a positive culmination for us shareholders of GCAN.
v/r
Sterling
Chartmaster
1 week ago
Chart shows why I'm so bullish, we broke out to blue skies, then filled the gap and retested the BSB line at 6's, now up up and away we go! Classic, and I mean CLASSIC bottoming chart formation!
And look at the bottom chart from 2021 that I posted in Jan 2021, it shows similar BSB and back then GCAN went to .0241, so I am expecting .02 here, makes charting sense. So glad to see you here stervc, you bring class to trading!
2021 chart, looks similar
Chartmaster
1 week ago
2025 news is out: GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing
Company today announced a major strategic step forward as it explores new growth avenues
Artificial Intelligence (AI) and Quantum Computing industries represent multi-trillion dollar market opportunities1,2
Company is committed to maximize shareholder value through evaluation of strategic options
BALTIMORE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation therapeutics would like to update its shareholders that has initiated a process to explore strategic alternatives to maximize shareholder value. The Company will continue to pursue its existing biopharma lines of business while evaluating a range of strategic options to maximize value for its shareholders. The business fields of quantum computing and AI are seen as the next frontier in emerging technologies, and have quickly developed into multi-billion dollar industries.
Aitan Zacharin, Chief Executive Officer, had this to say, “There have been a number of companies focused on developing these cutting edge technologies who have approached GCAN expressing interest in a potential merger, and as part of our fiduciary obligation to our shareholders we will explore these options. We look forward to updating our shareholders with continued developments.”
As part of the evaluation process GCAN will explore potential strategic alternatives that may include, but are not limited to a sale, merger, strategic business combination or other transaction. The Company cannot assure that its exploration will result in a transaction or that any transaction, if pursued, will be completed on attractive terms, if at all. The Company has not set a timetable for completion of the evaluation process. GCAN will make further announcements in accordance with its ongoing disclosure obligations and pursuant to applicable laws and regulations.
ENDS
For GCANRx Investor Relations inquiries visit www.gcanrx.com, or contact info@gcanrx.com. To receive the latest information about GCANRx sign up to the investor email at https://bit.ly/2ZNlBoj or follow @GCANRX on Twitter.
1 https://www.mckinsey.com/featured-insights/the-rise-of-quantum-computing
2 https://www.bloomberg.com/company/press/generative-ai-to-become-a-1-3-trillion-market-by-2032-research-finds/
About Greater Cannabis Company: The Greater Cannabis Company (OTC: GCAN), (“GCANRx” or the “Company”) is a publicly traded clinical stage biopharmaceutical company focused on the development of new and effective cannabinoid therapeutics. The Company conducts medical research, and is pursuing clinical trials, to develop innovative cannabis-based treatments for various medical conditions and their symptoms with an initial focus on neuropsychiatric disorders. GCANRx’s mission is to bring its products to the global market for the benefit of patients seeking better solutions for their unmet medical needs.
Forward-Looking Statements: This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions.
These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential, "predict," "project," "should," "would" and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company's filings with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact: The Greater Cannabis Company, Inc.
443-738-4051
info@gcanrx.com
www.gcanrx.com
https://www.globenewswire.com/newsroom/ti?nf=OTMyNTc2NiM2Njc2NDcxIzUwMDA1MDM4OA==
https://ml.globenewswire.com/media/MTFmZDFmNWYtYmE4My00NjFlLWIxZTktZjc0ZTI3ZmI4ZGI0LTUwMDA1MDM4OA==/tiny/Greater-Cannabis-Company-Inc-.png
Source: Greater Cannabis Company, Inc.
© 2025 GlobeNewswire, Inc.
https://www.otcmarkets.com/stock/GCAN/news/story?e&id=3089966